223 related articles for article (PubMed ID: 12660426)
1. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.
Aoki M; Pawankar R; Niimi Y; Kawana S
Int Arch Allergy Immunol; 2003 Mar; 130(3):216-23. PubMed ID: 12660426
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas.
Oh CK; Kwon YW; Kim YS; Jang HS; Kwon KS
J Dermatol; 2003 Apr; 30(4):306-13. PubMed ID: 12707467
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
4. Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES.
Kimura Y; Pawankar R; Aoki M; Niimi Y; Kawana S
Clin Exp Allergy; 2002 Dec; 32(12):1787-93. PubMed ID: 12653173
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Ohta M; Kitadai Y; Tanaka S; Yoshihara M; Yasui W; Mukaida N; Haruma K; Chayama K
Int J Cancer; 2002 Nov; 102(3):220-4. PubMed ID: 12397639
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.
Jee SH; Shen SC; Chiu HC; Tsai WL; Kuo ML
Oncogene; 2001 Jan; 20(2):198-208. PubMed ID: 11313947
[TBL] [Abstract][Full Text] [Related]
7. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
8. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma.
Sawatsubashi M; Yamada T; Fukushima N; Mizokami H; Tokunaga O; Shin T
Virchows Arch; 2000 Mar; 436(3):243-8. PubMed ID: 10782883
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
Kim HK; Song KS; Park YS; Kang YH; Lee YJ; Lee KR; Kim HK; Ryu KW; Bae JM; Kim S
Eur J Cancer; 2003 Jan; 39(2):184-91. PubMed ID: 12509950
[TBL] [Abstract][Full Text] [Related]
10. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
12. Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.
Koshikawa N; Iyozumi A; Gassmann M; Takenaga K
Oncogene; 2003 Oct; 22(43):6717-24. PubMed ID: 14555985
[TBL] [Abstract][Full Text] [Related]
13. Induction of IL-13 production and upregulated expression of protease activated receptor-1 by RANTES in a mast cell line.
Zhang H; Yang H; Ma W; He S
Cytokine; 2011 Feb; 53(2):231-8. PubMed ID: 21074454
[TBL] [Abstract][Full Text] [Related]
14. CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma.
Loggini B; Boldrini L; Gisfredi S; Ursino S; Camacci T; De Jeso K; Cervadoro G; Pingitore R; Barachini P; Leocata P; Fontanini G
Pathol Res Pract; 2003; 199(11):705-12. PubMed ID: 14708636
[TBL] [Abstract][Full Text] [Related]
15. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
17. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
18. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
19. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
20. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
